C12Y 304/13
Dipeptidases
Official title: Dipeptidases (3.4.13)
C12Y304/13 (Dipeptidases) appears on 24 US grants and 38 published applications in this corpus.
Search patents in C12Y- Granted patents
- 24
- Published applications
- 38
- Assignees
- 28
- Inventors
- 103
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 2 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 1 | 1 |
| 2013 | 2 | 3 |
| 2014 | 2 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 3 | 6 |
| 2018 | 1 | 2 |
| 2019 | 3 | 3 |
| 2020 | 0 | 4 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 3 | 0 |
| 2024 | 0 | 3 |
| 2025 | 0 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 304/13009Xaa-pro dipeptidase i.e. prolidase9
- C12Y 304/13019Membrane dipeptidase5
- C12Y 304/13018Cytosol nonspecific dipeptidase , i.e. glycyl-leucine dipeptidase4
- C12Y 304/13011Dipeptidase1
- C12Y 304/1302Beta-ala-his dipeptidase1
- C12Y 304/13022D-ala-d-ala dipeptidase1
- C12Y 304/13003Xaa-his dipeptidase0
- C12Y 304/13004Xaa-arg dipeptidase0
Recent patents
- DPEP-1 binding compositions and methods of use10 Mar 2026US 12,569,538 B2Arch Biopartners, Inc.
- Expression cassette26 Dec 2023US 11,851,684 B2Spiber Inc.
- Flavour generation in food14 Nov 2023US 11,812,755 B2Societe des Produits Nestle S. A.
- DPEP-1 binding compositions and methods of use6 Jun 2023US 11,666,631 B2Arch Biopartners, Inc.
- Flavour generation in food1 Nov 2022US 11,484,036 B2Societe des Produits Nestle S. A.
- Systems and methods for producing collagen 7 compositions23 Jul 2026US 2026/0209315 A1Phoenix Tissue Repair, Inc.
- Combination of garadacimab and prolidase for cancer therapy26 Feb 2026US 2026/0055208 A1
- Depleting egfr and her2 overcomes resistance to egfr inhibitors in colorectal cancer9 Jan 2025US 2025/0009852 A1Health Research, Inc.
- Means and methods for detoxifying ochratoxin a24 Oct 2024US 2024/0352438 A1DSM Austria GmbH
- Method for prophylaxis and/or treatment of erbb2 positive cancers5 Sep 2024US 2024/0293518 A1Health Research, Inc.
Most cited
By later US patents
- Method of treating rhinitis or sinusitis by intranasally administering a peptidase27US 6,337,069 B12002
- Asparaginases and method of preparing a heat-treated product12US 7,396,670 B2Novozymes A/S · 2008
- Collagen 7 and related methods9US 9,676,837 B2Shire Human Genetic Therapies, Inc. · 2017
- Production of wheat protein hydrolyzates by multistage hydrolysis with a proteinase and peptidase8US 5,945,299 AHenkel Kommanditgesellschaft auf Aktien (KGaA) · 1999
- Asparaginases and method of preparing a heat-treated product5US 8,124,396 B2Novozymes A/S · 2012